← Back to Search

Glucose Monitoring Device

ELG for Type 1 Diabetes

N/A
Waitlist Available
Led By Dr. Joe P Rouse, MD
Research Sponsored by XP Technology, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up this visit will be measured within a 4 week time frame, following the 1st visit. this visit will last for up to 1-2 hours. this outcome will measure non-fasting results.
Awards & highlights

Study Summary

This study is evaluating whether a new device can measure blood glucose levels without taking blood samples.

Eligible Conditions
  • Type 1 Diabetes
  • Type 2 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~this visit will be measured within a 4 week time frame, following the 1st visit. this visit will last for up to 1-2 hours. this outcome will measure non-fasting results.
This trial's timeline: 3 weeks for screening, Varies for treatment, and this visit will be measured within a 4 week time frame, following the 1st visit. this visit will last for up to 1-2 hours. this outcome will measure non-fasting results. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Standard OTC Glucose, A1C & Laboratory Results in Comparison to ELG Device During Fasting Event
Standard OTC Glucose, A1C & Laboratory Results in Comparison to ELG Device During Non-Fasting Event

Trial Design

1Treatment groups
Experimental Treatment
Group I: ELG Device Comparison to Whole Blood TestingExperimental Treatment1 Intervention
Participant will place thumb in the ELG device for scan. Scan generally takes between 1-2 minutes. ELG then displays a readout of both a glucose and A1C reading on the screen of the ELG device.

Find a Location

Who is running the clinical trial?

XP Technology, LLCLead Sponsor
Dr. Joe P Rouse, MDPrincipal Investigator
Dr. Peter P Xaysanasy, DPMStudy DirectorXP Technology, LLC

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
The ELG Analysis of Glucose a Correlational to Blood Glucose Assay
2021. "The ELG Analysis of Glucose a Correlational to Blood Glucose Assay". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05055804.
~27 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top